Safety and efficacy of Temsirolimus in combination with Bendamustine and Rituximab in relapsed mantle cell and follicular lymphoma

Erstveröffentlichung
2015
Metadata only
Search for full text
Wissenschaftlicher Artikel


Authors
Hess, G.
Keller, U.
Scholz, C. W.
Witzens-Harig, M.
Atta, J.
et al.
Institutions
UKU. Institut für Experimentelle Tumorforschung
UKU. Klinik für Innere Medizin III
Published in
Leukemia ; 29 (2015), 8. - S. 1695-1701. - ISSN 0887-6924. - eISSN 1476-5551
Link to publication
https://dx.doi.org/10.1038/leu.2015.60
Keywords
NON-HODGKINS-LYMPHOMA; MULTICENTER PHASE-II; SINGLE-AGENT TEMSIROLIMUS; STUDY-GROUP GLSG; B-CELL; PLUS RITUXIMAB; CLINICAL-TRIAL; LENALIDOMIDE; INDOLENT; DEXAMETHASONE
Dewey Decimal Group
DDC 610 / Medicine & health
Metadata
Show full item record